Loading CAPR charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading CAPR comparable companies…
| CAPRCapricor Therapeutics, Inc.(opens in a new tab) | $0.37B | $0.02B | −11.5% | — | — | — | — |
|---|---|---|---|---|---|---|---|
| NXTCNextCure, Inc.(opens in a new tab) | $0.03B | $0.02B | +252.6% | — | — | — | — |
| PRLDPrelude Therapeutics Inc(opens in a new tab) | $0.38B | $0.02B | +220.3% | — | −300.6% | 17.07× | — |
| JANXJanux Therapeutics, Inc.(opens in a new tab) | $1.10B | $0.02B | +5367.0% | — | −598.1% | 45.87× | — |
| ABEOAbeona Therapeutics Inc.(opens in a new tab) | $0.25B | $0.03B | — | 67.1% | −327.6% | 9.75× | — |
| Medianpeers, excl. CAPR | $0.32B | $0.02B | +252.6% | 67.1% | −327.6% | 17.07× | — |